Clinical Trial

Brazilian Clinical Registry of Heart Transplantation

Study acronym: HESTIA
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 11, 2024 (before its estimated August 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
Prospective cohort clinical study, registry-based, multicenter, national, with the consecutive inclusion of patients with a history of Heart Transplantation in Brazil. The clinical registry will involve the participation until 25 centers. Patients will be included up to 30 days after Heart Transplant surgery and will be followed for one year. Laboratory tests and clinical parameters wil be collected in two clinical visits (6mo and 12 mo). The outcomes evaluate will be the total hospitalizations and all-cause death. It is expected to include 730 patients with a 12-month follow-up from the day of the transplant surgery. The findings of the HESTIA Registry may guide the management of post-heart transplant patients, aiming at reducing morbidity and mortality within 12 months after heart transplant surgery.
Trial Details
NCT Number NCT06453148
Lead Sponsor Hospital Israelita Albert Einstein
Conditions Heart Transplant Failure and Rejection, Heart Transplant
Enrollment 730 participants
Start Date 2024-08-25
Primary Completion 2024-08-31 (estimated)
Study Completion 2027-08-25 (estimated)
Updated on ClinicalTrials.gov 2024-06-11